A 61-year-old woman was referred to our clinic with an intact parathyroid hormone (PTH) level of 164 pg/ ml (normal: 12 to 65) and a serum calcium level of 11.8 mg/dl (normal: 8.3 to 10.7). She had undergone sestamibi scanning at her local nuclear medicine department, which had showed retained radio pharmaceutical within the entire right thyroid lobe and the upper portion of the left lobe. Because the results of the sestamibi scanning had been inconclusive, we ordered magnetic resonance imaging (MRI) of the neck with gadolinium contrast. The MRI showed a 1.7 X 1.2 x 1.8-cm, T2-hyperintense, T1-isointense mass posterior to the inferior right thyroid lobe and extending into the superior mediastinum (figure 1). These findings were consistent with a parathyroid adenoma and were confirmed surgically and pathologically.
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A second patient, a 46-year-old woman, was referred to our clinic with an intact PTH level of 205 pg/ml and a serum calcium level of l1.3mg/dl. High-resolution ultrasonography of her neck revealed a 0.9 X 0.72 x O.72-cm right lower thyroid lobe nodule and a 0.8 x 0.7 x 0.62-cm left lower thyroid lobe nodule. MRI of the neck with gadolinium contrast showed a 0.8 X 0.7-cm , T2-hyperintense, Tl-hypointense right-sided nodule consistent with parathyroid adenoma (figure 2). No masses were seen on the left side. Again, the MRI findings were confirmed surgically and pathologically.
Preoperative localization of a parathyroid adenoma in primary hyperparathyroidism has gained significance since the advent of minimally invasive procedures . Several imaging modalities are available, including ultrasonography, sestamibi scanning, and MRI. . Ultrasonography offers the advantages of being cost-effective, noninvasive, and rapid when done in the physician's office. Some drawbacks to ultrasonog-From the Osborne Head and Neck Institute, Los Angeles. raphy include its inability to reliably detect retrosternal and retroesophageal adenomas. Ultrasound is also operator-dependent, and the surgeon is rarely able to objectively review the study independently. In the past, radiologists primarily performed this test; today, however, endocrinologists and surgeons trained in ultrasonography are now performing it in their offices.
In 2009, Akinci et al evaluated the accuracy oflocalizing adenomas via ultrasonagraphy when performed by endocrinologists vs. radio logists. They found that radiologists performing ultrasonography localized 53% of parathyroid adenomas, while endocrinologists using ultrasonography localized 65% of parathyroid adenomas. They concluded that endocrinologist-performed ultrasonography improves preoperative localization of parathyroid adenomas.'
Sestamibi scanning is often used in conjunction with ultrasonography for preoperative parathyroid adenoma localization. In 2009, Tublin et al found that tamibi scanning in 89% of patients.' The differin g results in these studies exemplify th e variability th at can occur between different institutions. MRI has been used less frequently for localization of parathyroid adenomas, most likely because of cost an d availability. However, there are several benefits to this imaging modality: MRI can identify retrosternal or retroesphageal adenomas, and it provides objective results that can be reviewed by the surgeon. A review of the literature shows that the reliability of MRI in localizing parathyroid adeno mas has not been directly studied. However, in 2008, Munk et al used MRI as a confirm atory study when findin gs of ult rason ography and sestam ibi scanning differed. Th e authors fou nd that when the MRI agreed with either the ultrasou nd or the sestam ibi scan, the adenoma was accurately localized 100% of th e time .
Surgeons who perform parathyroid surgery on a regular basis for th e management of primary hyperpa rathyroidis m generally are dealing with a case of a single parathyroid ade noma. Minimally invasive parathyroid surgery is no lon ger a new trend but arguab ly has become th e standard of care. Altho ugh different techniques fall under the um brella of minimally invasive parathyroid surgery, they all depend on some sort of reliable localization study. The inability to localize the diseased gland can turn a fairly short operation into a long, extensive dissection . Surgeons being referred these cases from various sources will no dou bt encounte r patients with a variety of preoperative workup s and localization stud ies. Our two cases illustrate the usefulness of MRI in th e identificatio n of parathyroid adeno mas. The decision as to which modality will be used for preoperative localization of a parathyroid adenoma should be based on the reliabilit y of each individual test at each specific institution. 
